神経治療学
Online ISSN : 2189-7824
Print ISSN : 0916-8443
ISSN-L : 2189-7824
シンポジウム7:炎症性ミオパチーの病態と治療
炎症性筋疾患の筋症候と治療
神田 隆
著者情報
ジャーナル フリー

2023 年 40 巻 3 号 p. 349-350

詳細
抄録

Proximal muscle dominant weakness has long been emphasized in inflammatory myopathy patients except inclusion body myositis (PM/DM). This is of course true, but it is necessary to recognize that most frequently and intractably involved muscles in PM/DM are neck flexor and trunk muscles. In addition to muscles in four extremities, routine evaluation of MMT in neck flexor and pectoralis major muscles is mandatory in general practice of PM/DM patients. Although glucocorticoids, immunosuppressants, and intravenous immunoglobulin are mainstay in PM/DM treatment at present, an individual treatment regimen will develop based on the recent classification of PM/DM. A lot of novel drugs including alpha–interferon antibody, C5 antibody and JAK inhibitors are waiting.

著者関連情報
© 2023 日本神経治療学会
前の記事 次の記事
feedback
Top